Skip to main content

Renovacor, Inc.

RCORDelisted Dec 1, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001799850

Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Renovacor, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of RCOR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders2427+3
Shares7.91M7.32M−594.8K (−7.5%)
Value$16.0M$18.4M+$2.40M (+14.9%)

New holders (6)

Institutions that held Renovacor, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to RCOR in Q3 2022
InstitutionSharesValue% of portfolio
Clear Harbor Asset Management, LLC51,560$130.0K0.02%
CSS LLC20,700$52.0K0.00%
Bank of America Corp1,174$3.00K0.00%
Barclays PLC380$1.00K0.00%
Citigroup Inc401$1.00K0.00%
Royal Bank of Canada171$00.00%

Sold out (3)

Institutions that held Renovacor, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of RCOR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Cormorant Asset Management, LP500,000$1.01M
Murchinson Ltd.15,886$32.0K
UBS Group AG3,120$6.00K